NM

Nomura Holdings, Inc.

NMRFinancial ServicesNASDAQ

Capital Markets · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.84T
+10.8% YoY
Net Income
$362.13B
+6.3% YoY

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 1 MACD Positive CrossoverHistogram +0.0340, positive momentum
Aug 31 MACD Positive CrossoverHistogram +0.0310, positive momentum
About Nomura Holdings, Inc.

Nomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide. With a market capitalization of $31.13B, it sits in large-cap territory. It operates through three segments: Wealth Management, Investment Management, and Wholesale.

Where NMR stands vs its 150-day and 200-day moving averages

As of the September 1, 2026 close, NMR finished 16.08% above its 150-day moving average ($8.77) and 18.10% above its 200-day moving average ($8.62). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is NMR overbought or oversold?

At the September 1, 2026 close, NMR's RSI(14) was 61.5, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$31.13B
P/E (TTM)12.68
Fwd P/E19.02
EPS$0.84
Beta0.61
52W Change+43.9%
Dividend Yield3.04%
ROE11.2%
Analysis

With $53.17T in cash and $37.76T in debt, NMR maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Return on equity stands at 11.2%, which is decent for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 0.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.14T (2023) to $1.84T (2026), reflecting a 61% increase over the period.

The relatively low beta of 0.61 suggests NMR is a less volatile holding compared to the broader index. No single metric tells the full story. Reviewing NMR's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms